Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-phenyl-2-(dimethylaminoethoxy)-1,7,7-trimethylbicyclo(2.2.1)heptane Hemifumarate
2. Deramciclane
3. Deramciclane, (1r,2s,4r)-isomer
4. Deramciclane, (endo-egyt 3886)-isomer
5. Egis 3886
6. Egis-3886
7. Egis3886
8. Egyt 3886
9. Egyt-3886
10. N,n-dimethyl-2-((1,7,7-trimethyl-2-phenylbicyclo(2.2.1)hept-2-yl)oxy)ethamine
1. 120444-72-6
2. W1183ty0ee
3. Egis-3886
4. Exo-egyt 3886
5. Egyt-3886
6. Ethanamine,n,n-dimethyl-2-[[(1r,2s,4r)-1,7,7-trimethyl-2-phenylbicyclo[2.2.1]hept-2-yl]oxy]-, (2e)-2-butenedioate (1:1)
7. Egis 3886
8. Unii-w1183ty0ee
9. 2-phenyl-2-(dimethylaminoethoxy)-1,7,7-trimethylbicyclo(2.2.1)heptane Hemifumarate
10. Schembl3138093
11. Schembl7943241
12. Deramciclane Fumarate [mi]
13. 120444-72-6 (fumarate)
14. Bd170166
15. Ethanamine, N,n-dimethyl-2-(((1r,2s,4r)-1,7,7-trimethyl-2-phenylbicyclo(2.2.1)hept-2-yl)oxy)-, (2e)-2-butenedioate (1:1)
16. Ethanamine, N,n-dimethyl-2-((1,7,7-trimethyl-2-phenylbicyclo(2.2.1)hept-2-yl)oxy)-, (1r-exo)-, (e)-2-butenedioate (1:1)
17. Q27292167
18. (1r,2s,4r)-n,n-dimethyl-2-((1,7,7-trimethyl-2-phenylbicyclo[2.2.1]hept-2-yl)oxy)ethanamine 2(e)-butenedioate
19. (e)-but-2-enedioic Acid;n,n-dimethyl-2-[[(1r,2s,4r)-1,7,7-trimethyl-2-phenyl-2-bicyclo[2.2.1]heptanyl]oxy]ethanamine
20. N,n-dimethyl-2-(((1r,2s,4r)-1,7,7-trimethyl-2-phenylbicyclo[2.2.1]heptan-2-yl)oxy)ethan-1-amine Fumarate
| Molecular Weight | 417.5 g/mol |
|---|---|
| Molecular Formula | C24H35NO5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 417.25152322 g/mol |
| Monoisotopic Mass | 417.25152322 g/mol |
| Topological Polar Surface Area | 87.1 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 518 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
ABOUT THIS PAGE
80
PharmaCompass offers a list of Deramciclane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deramciclane manufacturer or Deramciclane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deramciclane manufacturer or Deramciclane supplier.
PharmaCompass also assists you with knowing the Deramciclane API Price utilized in the formulation of products. Deramciclane API Price is not always fixed or binding as the Deramciclane Price is obtained through a variety of data sources. The Deramciclane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Deramciclane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deramciclane, including repackagers and relabelers. The FDA regulates Deramciclane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deramciclane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Deramciclane supplier is an individual or a company that provides Deramciclane active pharmaceutical ingredient (API) or Deramciclane finished formulations upon request. The Deramciclane suppliers may include Deramciclane API manufacturers, exporters, distributors and traders.
Deramciclane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Deramciclane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Deramciclane GMP manufacturer or Deramciclane GMP API supplier for your needs.
A Deramciclane CoA (Certificate of Analysis) is a formal document that attests to Deramciclane's compliance with Deramciclane specifications and serves as a tool for batch-level quality control.
Deramciclane CoA mostly includes findings from lab analyses of a specific batch. For each Deramciclane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Deramciclane may be tested according to a variety of international standards, such as European Pharmacopoeia (Deramciclane EP), Deramciclane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Deramciclane USP).
